9 May 2024

VIVEbiotech is participating at the American Society of Gene & Cell Therapy´s Annual Meeting in Baltimore

VIVEbiotech is participating at the American Society of Gene & Cell Therapy´s (ASGCT) Annual Meeting at the Baltimore Convention Center.

Read more

10 April 2024

VIVEbiotech participates in Cell & Gene Meeting on the Mediterranean

VIVEbiotech participates in Cell & Gene Meeting on the Mediterranean that is taking place these days in the beautiful city of Rome.

Read more

19 March 2024

VIVEbiotech is participating in the 19th edition the Advanced Therapies Congress

VIVEbiotech is participating in the 19th edition the Advanced Therapies Congress that has just started and will take place today and tomorrow at the ExCel...

Read more

13 March 2024

VIVEbiotech contributes to a roundtable article in Pharma´s Almanac

VIVEbiotech has contributed to a roundtable article in Pharma's Almanac discussing strategies being employed to accelerate product development and commercialization without compromising quality.

Read more

6 March 2024

VIVEbiotech receives the EmakumeEkinn award for promoting innovation and female talent

On the occasion of the celebration of International Women's Day, the Sociedad Fomento San Sebastián has made today a recognition to women who contribute...

Read more

4 March 2024

Spanish researchers to design proteins using AI to make advanced therapies more efficient

The Ministry of Science, Innovation and Universities in collaboration with the Center for Technological Development and Innovation (CDTI) have selected it as one of the 40...

Read more

20 February 2024

Scrip Citeline Commercial reports VIVEbiotech’s predictions for 2024

At the end of 2023, Scrip Citeline Commercial gave us the opportunity to provide predictions for the year ahead.

Read more

14 February 2024

VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024

Pharma Manufacturing asked Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, about her predictions on therapeutic advances for 2024.

Read more

13 February 2024

VIVEbiotech presents at a Gyrolab Technology Seminar

Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist at VIVEbiotech, will be presenting today at a Gyrolab Technology Seminar.

Read more

9 February 2024

VIVEbiotech participates in an article in Endpoints News about the challenges facing lentiviral vector production

VIVEbiotech participates in an article in Endpoints News about the challenges facing lentiviral vector production.

Read more